Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126466391 | 12646639 | 1 | I | 20160630 | 20160801 | 20160812 | 20160812 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063810 | BRISTOL MYERS SQUIBB | 84.64 | YR | F | Y | 0.00000 | 20160812 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126466391 | 12646639 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 2 MG, QD | Y | 9218 | 2 | MG | TABLET | QD | |||||
| 126466391 | 12646639 | 2 | I | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Oral | 500 MG, TID | U | 0 | 500 | MG | FILM-COATED TABLET | TID | |||||
| 126466391 | 12646639 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 126466391 | 12646639 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 126466391 | 12646639 | 5 | C | CANDESARTAN | CANDESARTAN | 1 | Unknown | Y | 0 | ||||||||||
| 126466391 | 12646639 | 6 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | 0 | ||||||||||
| 126466391 | 12646639 | 7 | C | BRICANYL | TERBUTALINE SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 126466391 | 12646639 | 8 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | Unknown | U | 0 | ||||||||||
| 126466391 | 12646639 | 9 | C | LASILIX SPECIAL /00032601/ | FUROSEMIDE | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126466391 | 12646639 | 1 | Product used for unknown indication |
| 126466391 | 12646639 | 2 | Thrombophlebitis septic |
| 126466391 | 12646639 | 3 | Product used for unknown indication |
| 126466391 | 12646639 | 4 | Product used for unknown indication |
| 126466391 | 12646639 | 5 | Product used for unknown indication |
| 126466391 | 12646639 | 6 | Product used for unknown indication |
| 126466391 | 12646639 | 7 | Product used for unknown indication |
| 126466391 | 12646639 | 8 | Product used for unknown indication |
| 126466391 | 12646639 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126466391 | 12646639 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126466391 | 12646639 | Acute kidney injury | |
| 126466391 | 12646639 | International normalised ratio increased | |
| 126466391 | 12646639 | Labelled drug-drug interaction medication error |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126466391 | 12646639 | 1 | 2016 | 0 | ||
| 126466391 | 12646639 | 2 | 201606 | 20160704 | 0 |